[A three-week regimen of S-1 monotherapy reduced gastrointestinal toxicity and maintained efficacy in patients with gemcitabine-refractory advanced pancreatic cancer].
Hiroto Tanaka; Shuichi Mitsunaga; Misaki Kobayashi; Hideki Funazaki; Shiro Katayama; Akiko Kuwahara; Hiroyuki Okuyama; Hideaki Takahashi; Izumi Ohno; Satoshi Shimizu; Yasunari Sakamoto; Shunsuke Kondo; Chigusa Morizane; Hideki Ueno; Takuji Okusaka; Atsushi Ochiai; Masafumi Ikeda
Gan to kagaku ryoho. Cancer & chemotherapy 42 3 313 - 7 2015年03月
[査読有り]